Pasquale De Rosa
About
In The Last Decade
Pasquale De Rosa
36 papers receiving 770 citations
Peers
Comparison fields: 5 of 102
- Reproductive Medicine 296
- Public Health, Environmental and Occupational Health 287
- Pediatrics, Perinatology and Child Health 134
- Endocrinology, Diabetes and Metabolism 127
- Health, Toxicology and Mutagenesis 118
Countries citing papers authored by Pasquale De Rosa
This map shows the geographic impact of Pasquale De Rosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pasquale De Rosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pasquale De Rosa more than expected).
Fields of papers citing papers by Pasquale De Rosa
This network shows the impact of papers produced by Pasquale De Rosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pasquale De Rosa. The network helps show where Pasquale De Rosa may publish in the future.
Co-authorship network of co-authors of Pasquale De Rosa
This figure shows the co-authorship network connecting the top 25 collaborators of Pasquale De Rosa. A scholar is included among the top collaborators of Pasquale De Rosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pasquale De Rosa. Pasquale De Rosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 7 | |
| 4 | 3 | |
| 5 | 9 | |
| 6 | 12 | |
| 7 | 26 | |
| 8 | 5 | |
| 9 | 47 | |
| 10 | 7 | |
| 11 | 130 | |
| 12 | 34 | |
| 13 | High progesterone levels during the luteal phase related to the use of an aromatase inhibitor in breast cancer patients. | 10 |
| 14 | 42 | |
| 15 | 23 | |
| 16 | 6 | |
| 17 | 11 | |
| 18 | 24 | |
| 19 | 1 | |
| 20 | 77 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.